Effects of the Spinal Manipulative Therapy & Myofascial Release in

Status Completed

Clinical Trial Summary

The aim will be to compare a experimental group submitted to a protocol of spinal manipulation and myofascial release; and a control group composed by spinal manipulation only, in individuals with chronic non-specific low back pain. This is a randomized controlled trial, characterized by the application of manual therapy, in two modalities: spinal manipulation plus myofascial release and spinal manipulation alone. Participants will be enrolled and randomly allocated into two groups: 1) spinal manipulation plus myofascial release, totaling 6 sessions, 2x/week, for 3 weeks; 2) spinal manipulation: 6 sessions, 2x/week, for 3 weeks. Participants will be evaluated in two different moments: 1) Baseline (pre-intervention); 2) at the end of intervention period (3 weeks); and 3) after 3 months follow-up. The primary outcomes will be pain intensity (measured in centimeters with the visual analogue scale - VAS) and disability (measured by the Quebec questionnaire - QDS). The secondary outcomes will be muscle fatigue (measured by the Biering-Sorensen test), postural balance (measured by the Y Balance test), pain threshold (algometry, in kgf) and perception of recovery (Likert scale of 6-points) and health status (measured by the Eq5d3L questionnaire). Data analysis will be performed with the SPSS (Statistical Package for the Social Sciences) software version 24.0. Data normality assumptions will be confirmed by the Shapiro Wilk test. If the assumptions were met, a mixed ANOVA with repeated measures will be adopted, based on the outcomes and the independent variables (groups), for the comparison between pre-intervention and post-intervention. Spinal manipulation plus myofascial release is expected to have better effects than spinal manipulation alone, associated with the outcomes of interest.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03434990
Study type	Interventional
Source	University of Brasilia
Contact
Status	Completed
Phase	N/A
Start date	February 8, 2018
Completion date	September 17, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03243084` - Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy	N/A
Suspended	`NCT04735185` - Stem Cells vs. Steroids for Discogenic Back Pain	N/A
Completed	`NCT03162952` - RAND Center of Excellence for the Study of Appropriateness of Care in CAM
Completed	`NCT03240146` - Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain	N/A
Completed	`NCT05282589` - Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients	N/A
Completed	`NCT03637998` - Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain	N/A
Recruiting	`NCT02289170` - Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100)	N/A
Active, not recruiting	`NCT01944163` - The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain	N/A
Completed	`NCT02231554` - Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial	N/A
Recruiting	`NCT02063503` - Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients	N/A
Completed	`NCT01704677` - Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up	N/A
Terminated	`NCT01620775` - MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain	N/A
Completed	`NCT01490905` - A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain	Phase 4
Completed	`NCT01177254` - Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions	N/A
Completed	`NCT01177280` - Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes	N/A
Completed	`NCT01177241` - Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids	N/A
Completed	`NCT00984815` - Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment	Phase 3
Completed	`NCT00761150` - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)	Phase 3
Completed	`NCT00763321` - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)	Phase 3
Completed	`NCT00767806` - A Study for Patient With Chronic Low Back Pain	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effects of the Spinal Manipulative Therapy and Myofascial Release in Individuals With Non-specific Chronic Low Back Pain — ChiroRCT

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms